Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06150690

Study on Pancreatic Islets in Patients Undergoing (Partial) Pancreatectomy (PRECISE)

Study on the Function of Insulin-producing Beta Cells in the Human Pancreas

Status
Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
German Diabetes Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study investigates the mechanisms underlying the pathogenesis of diabetes by examining structural and functional properties of islets of Langerhans in pancreas specimen from patients undergoing (partial) pancreatectomy.

Detailed description

The study aims at elucidating the mechanisms underlying the pathogenesis of diabetes. In particular, the study focusses on detailed analyses of morphological and functional properties of pancreatic islets/insulin-producing beta cells in order to identify diabetes-associated alterations on cellular and molecular levels. To directly address the role of the endocrine (and exocrine) pancreas in the complex process of diabetes development, the examinations are performed in samples of human pancreatic tissue. To this end, biopsy specimen of pancreas and visceral adipose tissue are collected from patients with or without diabetes who undergo (partial) pancreatectomy. The samples are analysed for morphological alterations (e.g. size and distribution of pancreatic islets and beta cells, size of adipocytes) and functional changes (e.g. gene expression patterns as assessed from beta-cell derived RNA). In addition, patient characteristics such as age and disease duration are documented and clinical data including fasting concentrations of blood glucose, insulin and free fatty acids are collected. Specific diabetes-associated alterations of pancreatic islet / beta cells are assessed by associating variables of glucose- and lipid-homeostasis with parameters of beta cell function. The expected outcomes of the study will contribute to improve our knowledge of the so far largely unknown molecular and cellular mechanisms involved in the pathogenesis of diabetes.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionThe participants did not receive any study-specific intervention

Timeline

Start date
2012-08-21
Primary completion
2030-12-31
Completion
2035-12-31
First posted
2023-11-29
Last updated
2023-11-29

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06150690. Inclusion in this directory is not an endorsement.